A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

por Ackerman, Stacey, D’Ambrosio, Francis, Greiner, Jack V, Villanueva, Linda, Ciolino, Joseph B, Hollander, David A
Publicado 2013